Clinical features of hemodialysis patients with intimal versus medial vascular calcifications

Journal of Nephrology

Volumn 22, Issue 3, 2009, Pages 358-366

  Damjanovic, Tatjana ^a   Djuric, Zivka ^a   Schlieper, Georg ^b   Markovic, Natasa ^a   Dimkovic, Sinisa ^a   Radojicic, Zoran ^c   Krüger, Thilo ^b   Floege, Jürgen ^b   Dimkovic, Nada ^a  

^a ZVEZDARA UNIVERSITY MEDICAL CENTER   (Serbia)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c Institute of Forestry   (Serbia)

Author keywords

Arterial calcification; Arterial intima; Arterial media; Cardiovascular disease; Hemodialysis

Indexed keywords

CALCIUM; CHOLESTEROL; PHOSPHATE; TRIACYLGLYCEROL;

ADULT; ARTERY CALCIFICATION; ARTERY INTIMA PROLIFERATION; ARTERY MEDIA; ARTICLE; BODY MASS; CALCIUM BLOOD LEVEL; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ECHOGRAPHY; FEMALE; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PHOSPHATE BLOOD LEVEL; PREVALENCE; PROTEIN BLOOD LEVEL; PULSE PRESSURE; RADIOGRAPHY; RISK FACTOR; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; AGED; CALCINOSIS; COMPARATIVE STUDY; INTIMA; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; RENAL REPLACEMENT THERAPY; VASCULAR DISEASE;

AGED; CALCINOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; RENAL DIALYSIS; RISK FACTORS; TUNICA INTIMA; VASCULAR DISEASES;

EID: 69449100114     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Adragao T, Pires A, Lucas R, et al. A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients. Nephrol Dial Transplant. 2004;19:1480-1488.
2. Yildiz A, Tepe S, Oflaz H, et al. Carotid atherosclerosis is a predictor of coronary calcification in chronic haemodialysis patients. Nephrol Dial Transplant. 2004;19:885-891.
3. Amann K, Tyralia K, Gross ML, Eifert T, Adamczak M, Ritz E. Special characteristics of atherosclerosis in chronic renal failure. Clin Nephrol. 2003;60(Suppl 1):S13-S21.
4. Goodman GW. Importance of hyperphosphataemia in the cardio-renal axis. Nephrol Dial Transplant. 2004;19(Suppl 1):i4-i8.
5. Ketteler M, Schlieper G, Floege J. Calcification and cardiovascular health: new insights into an old phenomenon. Hypertension. 2006;47:1027-1034.
6. Goodman GW, London G, Amman K, et al. Vascular calcification in chronic kidney disease. Am J Kidney Dis. 2004;3:572-579.
7. London GM, Guérin AP, Marchais SJ, Métivier F, Pannier B, Adda H. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant. 2003;18:1731-1740.
8. Feigenbaum H. Echocardiographic evaluation of cardiac chambers (wall thickness, mass and stress). In: Faigenbaum H, ed. Echocardiography. 5th ed. Philadelphia, PA: Lea Febiger; 1994:134-173.
9. Krasniak A, Drozdz M, Pasowicz M, et al. Factors involved in vascular calcifications and atherosclerosis in maintenance haemodialysis patients. Nephrol Dial Transplant. 2007;22:515-521.
10. Moe MS, O'Neil KD, Fineberg N, et al. Assessment of vascular calcification in ESRD patients using spiral CT. Nephrol Dial Transplant. 2003;18:1152-1158.
11. Chertow G, Burke S, Raggi P. Sevelamer attenuates the progression of coronary and aortic calcifications in haemodialysis patients. Kidney Int. 2002;62:245-252.
12. Stompor TP, Pasowicz M, Sulowicz W, et al. Trend and dynamic of changes in calcification score over the 1-year observation period in patients on peritoneal dialysis. Am J Kidney Dis. 2004;44:517-528.
13. Okuno S. Presence of abdominal aortic calcifications is significantly associated with all-cause and cardiovascular mortality in maintenance haemodialysis patients. Am J Kidney Dis. 2007;49:417-425.
14. Bellasi A, Ferramosca E, Muntner P, et al. Correlation of simple imaging tests and coronary artery calcium measured by computed tomography in hemodialysis patients. Kidney Int. 2006;70:1623-1628.
15. Gross ML, Mayer HP, Ziebart H, et al. Calcification of coronary intima and media: immunohistochemistry, backscatter imaging, and X-ray analysis in renal and nonrenal patients. Clin J Am Soc Nephrol. 2007;2:121-134.
16. Wang AY, Woo J, Lam CW, et al. Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients. Nephrol Dial Transplant. 2005;20:1676-1685.
17. Yamada K, Fujimoto S, Mishiura R, et al. Risk factors of the progression of abdominal aortic calcification in patients on chronic hemodialysis. Nephrol Dial Transplant. 2007;22:2023-2037.
18. Raggi P, Boulay A, Chasan-Taber S, et al. Cardiac calcification in adult haemodialysis patients: a link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol. 2002;39:695-701.
19. Davies RM, Hruska AK. Pathophysiological mechanisms of vascular calcification in end-stage renal disease. Kidney Int. 2001;60:472-480.
20. Chertow MG, Raggi P, Chasan-Taber S, Bommer J, Holzer H, Burke SK. Determinants of progressive vascular calcification in haemodialysis patients. Nephrol Dial Transplant. 2004;19:1489-1497.
21. Cozzolino M, Brancaccio D, Gallieni M, Slatopolsky E. Pathogenesis of vascular calcification in chronic kidney disease. Kidney Int. 2005;68:429-436.
22. Chen NX. O Neill KD, Duan D, Moe MS. Phosphorous and uremic serum up- regulate osteopontin expression in vascular smooth muscle cells. Kidney Int. 2002;62:1755-1760.
23. Brancaccio D, Zoccali C. The continuous challenge of cardiovascular and bone disease in uremic patients: Clinical consequences of hyperphosphatemia and advanced therapeutic approaches. J Nephrol. 2006;19:12-20.
24. Cozzolino M, Staniforth ME, Liapis H, et al. Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia. Kidney Int. 2003;62:1653-1658.